Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology and psychiatry: the flawed approach to mental health outcomes measurement.

In an interview, Vincent Ma, MD, explores the clinical utility of circulating tumor DNA dynamics to assess early outcomes in ...

Vaping, cannabis use, alcohol use, prescription stimulant misuse—these, and other addictive behaviors, affect a substantial number of adolescents in the United States, yet how should clinicians ...